Mainelli Michael 4
4 · Xtant Medical Holdings, Inc. · Filed Oct 15, 2018
Insider Transaction Report
Form 4
Mainelli Michael
Director
Transactions
- Award
Stock Option (right to buy)
2018-10-15+240,000→ 240,000 totalExercise: $3.22Exp: 2028-10-15→ Common Stock (240,000 underlying)
Holdings
- 20,833
Common Stock, $0.000001 par value
Footnotes (2)
- [F1]These shares are subject to vesting pursuant to a restricted stock award granted under the Amended and Restated Xtant Medical Equity Incentive Plan.
- [F2]This option vests with respect to 10,000 of the shares subject to the option on the 15th day of each of the twenty-four (24) months commencing on November 15, 2018, subject to such Reporting Person's continued employment as Chief Executive Officer of Xtant Medical Holdings, Inc.